Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Alpha Teknova, Inc. TKNO
$2.01
+$0.15 (7.49%)
На 18:04, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
50212943.00000000
-
week52high
14.85
-
week52low
1.72
-
Revenue
41420000
-
P/E TTM
-1
-
Beta
0.00000000
-
EPS
-1.62000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 ноя 2022 г. в 21:30
Описание компании
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Stephens & Co. | Overweight | Overweight | 11 авг 2022 г. |
| Stephens & Co. | Overweight | Overweight | 16 мар 2022 г. |
| Stephens & Co. | Overweight | 20 июл 2021 г. | |
| Cowen & Co. | Outperform | 20 июл 2021 г. | |
| BTIG | Buy | 20 июл 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Terrill Damon | A | 30000 | 30000 | 15 ноя 2022 г. |
| Gelhaus Ken | A | 72500 | 72500 | 15 ноя 2022 г. |
| Gunstream Stephen | A | 87500 | 87500 | 15 ноя 2022 г. |
| Hood Lisa | A | 40498 | 40498 | 15 ноя 2022 г. |
| Hood Lisa | D | 31234 | 2046 | 15 ноя 2022 г. |
| Lowell Matthew | A | 33093 | 33093 | 15 ноя 2022 г. |
| Gelhaus Ken | A | 1422 | 1422 | 14 ноя 2022 г. |
| Gunstream Stephen | A | 61008 | 1716 | 14 ноя 2022 г. |
| Hood Lisa | A | 33280 | 2046 | 14 ноя 2022 г. |
| Gunstream Stephen | D | 886879 | 40000 | 30 сент 2022 г. |
Новостная лента
Alpha Teknova, Inc. (TKNO) Q3 2022 Earnings Call Transcript
Seeking Alpha
13 ноя 2022 г. в 04:42
Alpha Teknova, Inc. (NASDAQ:TKNO ) Q3 2022 Earnings Conference Call November 21, 2022 4:30 PM ET Company Participants Jennifer Henry - Senior Vice President of Marketing Stephen Gunstream - President & Chief Executive Officer Matthew Lowell - Chief Financial Officer Conference Call Participants Operator Good day, and thank you for standing by. Welcome to the Teknova Third Quarter 2022 Financial Results Conference Call.
Teknova to Participate in Upcoming Investor Conferences
GlobeNewsWire
03 ноя 2022 г. в 16:01
HOLLISTER, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, research, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will participate in the following upcoming investor conferences:
Teknova to Report Third Quarter 2022 Financial Results on November 9, 2022
GlobeNewsWire
26 окт 2022 г. в 16:01
HOLLISTER, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the third quarter ended September 30, 2022, on Wednesday, November 9, 2022, following the close of market.
Teknova to Participate in Upcoming Investor Conference
GlobeNewsWire
31 авг 2022 г. в 16:01
HOLLISTER, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will participate in the following upcoming investor conference.
Alpha Teknova, Inc. (TKNO) CEO Stephen Gunstream on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
10 авг 2022 г. в 19:43
Alpha Teknova, Inc. (NASDAQ:TKNO ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Sara Michelmore - Head of Investor Relations, MacDougall Advisors Stephen Gunstream - President & Chief Executive Officer Matthew Lowell - Chief Financial Officer Conference Call Participants Stephanie Yan - Cowen Matt Larew - William Blair Jake Johnson - Stephens Operator Good day, and thank you for standing by. Welcome to the Teknova Second Quarter 2022 Financial Results Conference Call.